Bayer Q2 preview: Focus on FX drag, pharma softness, and Roundup litigation overhang By Investing.com
- Posted on August 6, 2025
- By Investing.com
- 1 Views
Bayer Q2 preview: Focus on FX drag, pharma softness, and Roundup litigation overhang By Investing.com
Bayer Q2 preview: Focus on FX drag, pharma softness, and Roundup litigation overhang
